Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective
Author:
Funder
AstraZeneca
Novo Nordisk
Prometic
Sanofi
Eli Lilly
GlaxoSmithKline
Janssen
Lexicon
Medtronic
Merck
Novo Nordisk Canada Inc
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference71 articles.
1. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes, 2018;Diabetes Care,2018
2. Glycemic management in adults with type 1 diabetes;McGibbon;Can J Diabetes,2018
3. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49);Turner;JAMA,1999
4. Pharmacologic glycemic management of type 2 diabetes in adults;Lipscombe;Can J Diabetes,2018
5. Plasma insulin profiles after subcutaneous injection: How close can we get to physiology in people with diabetes?;Home;Diabetes Obes Metab,2015
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ultrafast-acting insulin: pharmacological properties and their impact on clinical aspects;Meditsinskiy sovet = Medical Council;2024-09-02
2. Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial;Diabetologia;2024-07-29
3. Hypoglycemic episodes among type 1 diabetic patients in Unaizah, Saudi Arabia: causes, management, and associated factors;Diabetes mellitus;2024-02-29
4. Maximizing Glycemic Benefits of Using Faster Insulin Formulations in Type 1 Diabetes: In Silico Analysis Under Open- and Closed-Loop Conditions;Diabetes Technology & Therapeutics;2023-04-01
5. Efficacy and Safety of Faster Aspart in Comparison to Insulin Aspart Among Indian Women with Gestational Diabetes;Current Diabetes Reviews;2022-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3